Retinal Ganglion Cells In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Retinal Ganglion Cells In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Retinal ganglion cells (RGCs) are the final output neurons of the retina, transmitting visual information to the brain. Their accessibility makes them important biomarkers for neurodegenerative diseases, as changes in RGC structure and function can reflect broader CNS pathology.
- Parvocellular pathway
- Color vision: Red-green
- High spatial frequency
- Small receptive fields
- Magnocellular pathway
- Motion detection
- High temporal frequency
- Large receptive fields
- Photosensitive RGCs: Melanopsin-containing
- Direction-selective: Motion-specific
- W cells: Broad spectrum
- Koniocellular: Various functions
- Thy-1: RGC surface marker
- Brn3a/3b/3c: Transcription factors
- Neurofilament: Structural proteins
- MAP2: Dendritic marker
- SMI-32: Non-phosphorylated neurofilament
- APP: Amyloid precursor protein
- Tau: Phosphorylated tau
- Alpha-synuclein: Lewy body component
- Contrast detection
- Color discrimination
- Motion perception
- Spatial resolution
- Pupillary light reflex
- Circadian entrainment
- Sleep regulation
- RGC loss: 20-40% reduction
- RNFL thinning: Retinal nerve fiber layer
- Vitreous biomarkers: Aβ detection
- Early marker: OCT changes
- RGC dysfunction: Prior to motor symptoms
- Melanopsin RGC: Light sensitivity changes
- Dopaminergic retina: Inner retinal changes
- Biomarker potential: Early diagnosis
- RGC apoptosis: Primary pathology
- Optic nerve degeneration: Progressive
- IOP relationship: Pressure-dependent
- Neuroprotection: Therapeutic target
- RGC loss: Optic neuritis aftermath
- Demyelination: Visual pathway
- OCT biomarkers: Disease progression
- Amyloid-beta: Retinal deposition
- Tau: Phosphorylation changes
- Alpha-synuclein: Lewy bodies
- Microglia: Activated in retina
- Cytokines: IL-6, TNF-α
- Complement: C3 activation
- Caspase-3: Executioner caspase
- Bcl-2 family: Mitochondrial pathway
- MAPK signaling: Stress response
- OCT: Retinal layer thickness
- Fundus photography: Structural changes
- Adaptive optics: Cellular resolution
- Vitreous Aβ: Correlation with brain
- Tau levels: Diagnostic potential
- NFL: Blood/CSF marker
- BDNF: Trophic support
- Antioxidants: Oxidative stress
- Anti-apoptotic: Caspase inhibitors
- AAV vectors: RGC targeting
- CRISPR: Genetic correction
- Optogenetics: Light sensitivity
Retinal Ganglion Cells In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Retinal Ganglion Cells In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- London A, et al. Retinal ganglion cells in neurodegeneration. Prog Retin Eye Res. 2013.
- Ikram MK, et al. Retinal imaging in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2012.
- Bodis-Wollner I. Retina in PD. Mov Disord. 2013.
- Weinreb RN, et al. Glaucoma. Nat Rev Dis Primers. 2020.
- Chang LY, et al. Retinal biomarkers for neurodegeneration. JAD. 2020.